Urogenital tract microbial community and mucosal surface (UGM)

The urogenital tract microbial community and mucosal surface represent a complex biological interface essential for maintaining reproductive and urinary health [1]. This system consists of a diverse population of commensal microorganisms, predominantly Lactobacillus species in the vaginal environment, which maintain an acidic pH and produce antimicrobial compounds to inhibit pathogens [2]. The mucosal surface provides a physical and immunological barrier, integrating host epithelial cells with the resident microbiota to prevent infections and inflammation [3]. Disruptions to this ecosystem, known as dysbiosis, are linked to conditions such as bacterial vaginosis, urinary tract infections, and increased susceptibility to sexually transmitted infections [4]. Therapeutic interventions targeting this system include antibiotics to eliminate pathogens, probiotics to restore healthy flora, and hormonal treatments to maintain mucosal integrity [5]. Sources: [1] NIH/NCBI: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134985/ [2] Nature Reviews Microbiology: https://www.nature.com/articles/s41579-020-00450-4 [3] Frontiers in Microbiology: https://www.frontiersin.org/articles/10.3389/fmicb.2021.631972/full [4] Microbiology and Molecular Biology Reviews: https://journals.asm.org/doi/10.1128/mmbr.00013-17 [5] Journal of Clinical Medicine: https://www.mdpi.com/2077-0383/10/21/5006

Other names

Urogenital microbiomeVaginal microbiomeUrinary microbiomeGenitourinary microbiotaUrogenital mucosal barrier

Restoration of microbial homeostasis, competitive inhibition of pathogens, acidification of the local environment, and enhancement of the host mucosal barrier.